Determination of some biochemical parameters in diabetic and hypertensive pregnant subjects in some referral hospitals
Table Of Contents
Chapter ONE
INTRODUCTION
- 1.1Introduction
- 1.2Background of Study
- 1.3Problem Statement
- 1.4Objective of Study
- 1.5Limitation of Study
- 1.6Scope of Study
- 1.7Significance of Study
- 1.8Structure of the Research
- 1.9Definition of Terms
Chapter TWO
LITERATURE REVIEW
- 2.1Overview of Diabetes
- 2.2Overview of Hypertension
- 2.3Biochemical Parameters in Diabetic Patients
- 2.4Biochemical Parameters in Hypertensive Patients
- 2.5Impact of Diabetes and Hypertension on Pregnancy
- 2.6Current Medical Management of Diabetic and Hypertensive Pregnant Patients
- 2.7Complications Associated with Diabetes and Hypertension in Pregnancy
- 2.8Studies on Biochemical Parameters in Diabetic and Hypertensive Pregnant Subjects
- 2.9Gaps in Literature
- 2.10Summary of Literature Review
Chapter THREE
RESEARCH METHODOLOGY
- 3.1Research Design
- 3.2Population and Sample Selection
- 3.3Data Collection Methods
- 3.4Data Analysis Techniques
- 3.5Ethical Considerations
- 3.6Validity and Reliability
- 3.7Research Limitations
- 3.8Timeframe and Budgeting
Chapter FOUR
DATA PRESENTATION AND ANALYSIS
- 4.1Participant Demographics
- 4.2Biochemical Parameters Analysis Results
- 4.3Comparison of Biochemical Parameters in Diabetic and Hypertensive Pregnant Subjects
- 4.4Correlation Analysis
- 4.5Discussion on Findings
- 4.6Recommendations for Clinical Practice
- 4.7Implications for Further Research
- 4.8Conclusion of Findings
Chapter FIVE
SUMMARY, CONCLUSION AND RECOMMENDATIONS
- 5.1Summary of Findings
- 5.2Conclusion
- 5.3Contributions to Knowledge
- 5.4Practical Implications
- 5.5Recommendations
Thesis Abstract
Abstract
Pregnancy-induced hypertension (PIH) and gestational diabetes mellitus (GDM) are common complications that can arise during pregnancy and pose risks to both the mother and the fetus. This study aimed to determine and compare some biochemical parameters in diabetic and hypertensive pregnant subjects in selected referral hospitals. The study was conducted in three referral hospitals, and a total of 150 pregnant women were recruited, with 50 in each group normotensive non-diabetic, hypertensive non-diabetic, and hypertensive diabetic. Biochemical parameters including fasting blood glucose, lipid profile (total cholesterol, triglycerides, HDL, LDL), and renal function markers (creatinine, urea) were measured and compared among the groups. The results showed that hypertensive diabetic pregnant women had significantly higher fasting blood glucose levels compared to normotensive non-diabetic and hypertensive non-diabetic pregnant women. Additionally, the lipid profile of hypertensive diabetic pregnant women showed higher total cholesterol and LDL levels compared to the other groups. Furthermore, the renal function markers in the hypertensive diabetic group indicated elevated levels of creatinine and urea, suggesting potential renal complications in this group. These findings highlight the importance of monitoring and managing these biochemical parameters in pregnant women with diabetes and hypertension to prevent adverse outcomes for both the mother and the baby. In conclusion, this study provides valuable insights into the differences in biochemical parameters among diabetic and hypertensive pregnant subjects. The results underscore the need for close monitoring and appropriate management of blood glucose levels, lipid profile, and renal function markers in pregnant women with these conditions. Early detection and intervention can help mitigate the risks associated with pregnancy-induced hypertension and gestational diabetes, ultimately improving maternal and fetal health outcomes. Further research is needed to explore additional factors that may influence these biochemical parameters in pregnant women with diabetes and hypertension.
Thesis Overview
<p>
</p><p><strong><br>1.0 INTRODUCTION</strong></p><p>Diabetes and hypertension in pregnant women as associated with an increase incidence of congenital abnormalities when compared with normal pregnancy (Hagay et al, 2005). Frequency of diabetic and hypertensive mother is estimated to be 6-10% (Hagay and Reece, 2006). Alteration in lipid profile is known to occur in diabetic and hypertensive pregnancy (Caron and Kjos, 2000).<br>In the present study, the following parameters were assessed in the serum to elucidate the biochemical profile status in pregnant women with diabetes and hypertensive (Kjos, 2000). Serum lipid profile parameters to be determined are total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), low density lipoprotein chore sterol (LDL-C) and triglyceride using Hitachi 902 Atom analyzer.<br>In reference to diabetes, the pregnant woman experiences physiological changes to support foetal growth and development. Pregnancy is associated with significant change in the functions of the normal liver. Although the precise mechanism underlying these various alterations is not clear in every case, their recognition is essential to a proper clinical evaluation (Angel, 2006). Lipid metabolism change during pregnancy (Brizzi et al, 2008) Natural rising of plasma lipid is seen in normal pregnancy, but this event is not atherogenic and it is believed that this process is under hormonal control (Rovinsky and gaffin, 2010). But in complicated pregnancy, there a possible defect in the mechanism of adjusting physiologic hyperlipidemia. Plasma lipid profile in the first trimester of pregnancy may predict the incidence and severity of pre-eclampsia. The anabolic phase of early pregnancy encourages lipogeneses and fat storage in preparation for rapid foetal growth in late pregnancy. Lipolysis is increased as a result of insulin resistance, leading to increased a s a result of insulin resistance, leading to increased flux of fatty acids to the liver promoting the synthesis of very low-density lipoprotein (VLDLS0 and increased triglyceride (TG) concentration (Ross, 2007). Because of a decrease in the activity of lipoprotein lipase, very-LDL remains in the plasma for longer and leads to the accumulation of LDL. An increase LDL is associated with the development of atherosclerosis (Ross, 2007). Abnormal lipid metabolism also seems important in the pathogenesis of pregnancy-included hypertension (PIH). Pregnancy included hypertension is characterized by elevated blood pressure, proteinuria, and edema (Dutta, 2001). Although considered to be relatively rare in the United States, PIH occurs world wide in from 2 to 35 percent of pregnancies, depending on diagnostic criteria and study of population. PIH is also called preclampsia and it occurs most often in young women with first pregnancy. It is more common in twin pregnancies, in with chronic hypertension, pre-existing diabetes, and in women who had PIH in a previous pregnancy. Hypertensive disorder of pregnancy, contribute significantly to serious complications for both the fetus and the mother (Hagay et al, 205). PIH occurs more frequently and is more severed women with preexisting hypertension then in women who are normotensive prior to pregnancy. The hypertensive disorder of pregnancy collectively represent a significant public health problem in the United States and throughout the world.<br>The cause and nature of this disorder is only partially understood (Angel, 2006). Therefore, the presence study was carried out to evaluate plasma lipid concentrations in normal and hypertensive pregnancy in order to establish whether hypertension includes abnormal lipid concentrations that could constitute potential metabolic risks factors for pregnancy complication.<br>Lipid profile in normal pregnant women, many scientific evidences have raise concern about the adverse effect of abnormal blood lipid levels, like cholesterol and other lipids and lipoproteins, on atherosclerotic disease (Gotto, 2009). The important attached to the need for routine examination of the serum lipid and lipoprotein profile in human subjects especially during pregnancy under disease condition such as diabetes and hypertension is well established (seggmour, 2006). Gotto, (2009) have revealed that serum lipid and lipoprotein profile varies with age, sex, diet and race. The serum protein and lipoprotein profile of many communities, remain to be established. This study was other fore, designed to access the variation of the serum lipid and lipoprotein profile among the diabetics, hypertensive and normal pregnant.</p>
<br><p></p>